Browsing by Author "McCauley, Marybeth"
Now showing items 1-20 of 33
-
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Tolley, Elizabeth E. et al. | Date Issued: 2020 -
Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples
Safren, Steven A. et al. | Date Issued: 2015 -
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial
Eshleman, Susan H. et al. | Date Issued: 2011 -
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
Cohen, Myron S. et al. | Date Issued: 2016 -
Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
Palumbo, Philip J. et al. | Date Issued: 2017 -
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
Fogel, Jessica M. et al. | Date Issued: 2016 -
Cabotegravir is not associated with weight gain in HIV-uninfected individuals in HPTN 077
Landovitz, Raphael J. et al. | Date Issued: 2019 -
Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus–uninfected Individuals in HPTN 077
Landovitz, Raphael J. et al. | Date Issued: 2020 -
Characterization of Human Immunodefciency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
Marzinke, Mark A. et al. | Date Issued: 2021 -
A comparison of hepatitis B virus infection in HIV-infected and HIV-uninfected participants enrolled in a multinational clinical trial: HPTN 052
Greer, Amy E. et al. | Date Issued: 2017 -
Comparison of hepatitis B virus infection in HIV-infected and HIV-uninfected participants enrolled in a multinational clinical Trial: HPTN 052
Greer, Amy E. et al. | Date Issued: 2017 -
Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots
Weld, Ethel D. et al. | Date Issued: 2023 -
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
Grinsztein, Beatriz et al. | Date Issued: 2014 -
Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial
Hanscom, Brett S. et al. | Date Issued: 2022 -
Evaluation of phylogenetic methods for inferring the direction of HIV transmission: HPTN 052
Zhang, Yinfeng et al. | Date Issued: 2020 -
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
Marzinke, Mark A. et al. | Date Issued: 2023 -
Features of HIV Infection in Long-Acting Cabotegravir PreExposure Prophylaxis
Landovitz, Raphael J. et al. | Date Issued: 2024 -
Features of HIV Infection in Long-Acting Cabotegravir PreExposure Prophylaxis
Landovitz, Raphael J. et al. | Date Issued: 2024 -
HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084
Fogel, Jessica M. et al. | Date Issued: 2025 -
HIV drug resistance in adults receiving early versus delayed antiretroviral therapy: HPTN 052
Palumbo, Philip J. et al. | Date Issued: 2018